Clinical Trial Update: Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 extension and open-label study of Gel-200 in knee osteoarthritis completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Gel-200 (hyaluronic acid)

Snippet

Sponsor: Seikagaku Corporation | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2011-08-22